Weil, Gotshal & Manges (Washington)

Steven Bernstein

Weil, Gotshal & Manges (Washington)
Lawyer (Partner)

Steven Bernstein, a partner in the Washington, D.C. office, focuses on antitrust counseling and litigation, with an emphasis on mergers and acquisitions. Prior to joining the Firm, he served for more than 12 years at the Federal Trade Commission, most recently as Assistant Director of the FTC’s Bureau of Competition, where he oversaw the Bureau’s Mergers I Division. Since joining Weil in 2004, Mr. Bernstein has represented numerous clients before the FTC and the Department of Justice and has successfully obtained antitrust clearance for major transactions in a variety of industries. Recent successes include representing Actavis in its $66 billion acquisition of Allergan, Johnson & Johnson in its $21.3 billion purchase of Synthes, and Health Management Associates in the sale of the company to Community Health Systems for $7.6 billion. Mr. Bernstein also regularly represents clients in antitrust conduct matters before the antitrust enforcement agencies and in private litigation. While at the FTC, Mr. Bernstein was involved in supervising the FTC’s merger enforcement program in a wide range of industries, including aerospace and defense, healthcare, and industrial products. Mr. Bernstein played a significant role in a number of important antitrust enforcement actions in these industries, including the successfully litigated challenge of Alliant Techsystems’ proposed acquisition of Olin’s Ordnance Division. He was also responsible for negotiating numerous consent agreements, including settlements in Lockheed Martin/Loral, Astra/Zeneca, Boeing/Rockwell Aerospace and Defense, ABB/Elsag Bailey, Illinois Tool Works/Hobart Brothers, and S.C. Johnson/DowBrands. Mr. Bernstein is consistently recognized in Chambers USA, with clients and commentators noting that he is a “super-smart guy with years and years of experience,” has a “can-do attitude” and is “really prepared to get through the process in a very efficient way, and is technically superb as well.” He has also been recognized by Global Competition Review, Legal 500 US, Euromoney Legal Media Group’s Expert Guides, Super Lawyers, and was named a “Best Lawyer” for Antitrust Law and Litigation – Antitrust by Best Lawyers in America. Mr. Bernstein was named an Antitrust “Trailblazer” by The National Law Journal in 2016. He also has received numerous awards at the FTC, including the Paul Rand Dixon Award for his outstanding contributions to the FTC’s merger enforcement program in the defense industry, the FTC’s Excellence in Supervision Award, the Outstanding Team Effort Award, the FTC Award for Superior Service, and the FTC Award for Meritorious Service. In 2002, Mr. Bernstein was recognized by Corporate Board Member magazine as one of the nation’s best and brightest attorneys under the age of 40. Mr. Bernstein has also written articles discussing the role of antitrust enforcement in the defense, pharmaceutical, and retail industries, and served on the editorial board for the American Bar Association Pharmaceutical Industry Antitrust Handbook. In addition, he participated in the development of the FTC Best Practices Guidelines for Merger Investigations, as well as served as vice chair of the Government Litigation Committee of the ABA’s Antitrust Section.

Linked authors

Weil, Gotshal & Manges (Washington)
Weil, Gotshal & Manges (Washington)
Weil, Gotshal & Manges (Washington)
Weil, Gotshal & Manges (New York)
Weil, Gotshal & Manges (Paris)

Articles

60 Bulletin

Steven Bernstein The US FTC and DoJ publish a joint statement in order to protect employers, staffing companies, recruiters and others against anticompetitive conduct in the labor markets during the COVID-19 crisis

60

Federal Trade Commission and Justice Department Issue Joint Statement on COVID-19 and Competition in U.S. Labor Markets* As individuals across the country are working on the front lines of the COVID-19 pandemic as essential service providers, the federal antitrust regulators announced that (...)

Send a message